TCHP Regimen
**Semantic type:** Therapeutic or Preventive Procedure
**Definition:** A regimen consisting of docetaxel, carboplatin, trastuzumab and pertuzumab, used as a neoadjuvant or adjuvant treatment for HER-2/neu-positive breast cancer.
**Synonyms:** - Docetaxel/Carboplatin/Pertuzumab/Trastuzumab - Docetaxel/Carboplatin/Trastuzumab/Pertuzumab Regimen - TCH + P - TCH + Pertuzumab - TCH Plus Pertuzumab Regimen - TCHP - TCHP - TCHP (Docetaxel) - TCHP (Docetaxel) (trastuzumab-anns) - TCHP (Docetaxel) (trastuzumab-dkst) - TCHP (Docetaxel) (trastuzumab-dttb) - TCHP (Docetaxel) (trastuzumab-herw) - TCHP (Docetaxel) (trastuzumab-pkrb) - TCHP (Docetaxel) (trastuzumab-qyyp) - TCHP (Docetaxel) (trastuzumab-strf) - TCHP (Docetaxel) (trastuzumab-zerc) - TCHP (Docetaxel, SC Trastuzumab) - Taxotere-Carboplatin-Herceptin-Perjeta - Taxotere-Carboplatin-Herceptin-Pertuzumab
/api/v1/systems/nci_thesaurus/nodes/C138047Hierarchy Explorer
Cross-system equivalences0
No cross-system equivalences mapped for this node.